Bio-Works Technologies is a biotechnology company. The company develops products that separate and purify molecules in the production of drugs. The technology is based on chromatography that aims to handle the drug substance. Customers are found in the European market where products are sold through distribution partners and to companies in the pharmaceutical industry. They are also sold to research institutes and universities. The company was founded in 2006 and is headquartered in Uppsala.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Staffan Persson | 18,79 | 18,79 | 2024-12-23 |
| Erik Åfors | 15,72 | 15,72 | 2024-12-23 |
| Avanza Pension | 5,82 | 5,82 | 2024-12-23 |
| Peter von Ehrenheim | 3,29 | 3,29 | 2024-12-23 |
| Dariush Hosseinian | 3,21 | 3,21 | 2024-12-23 |
| Futur Pension | 2,71 | 2,71 | 2024-12-23 |
| Laurent Leksell med bolag | 2,52 | 2,52 | 2024-12-23 |
| Nordnet Pensionsförsäkring | 2,24 | 2,24 | 2024-12-23 |
| Mathias Johansson | 1,99 | 1,99 | 2024-12-23 |
| Olof Mathias Malmgren | 1,71 | 1,71 | 2024-12-23 |
2025-05-16 Årsstämma 2024
2025-08-22 Delårsrapport 2025-Q2
2026-02-20 Bokslutskommuniké 2025
